SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-021821
Filing Date
2009-09-28
Accepted
2009-09-28 13:22:42
Documents
2
Period of Report
2009-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 9760
2 MISCELLANEOUS EXHIBITS misc1.htm EX-99.1 25449
  Complete submission text file 0001140361-09-021821.txt   38976
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091089723

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
SIGMA TAU INTERNATIONAL SA (Reporting) CIK: 0001170881 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091089722

Mailing Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877
Business Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877 1-800-447-0169
Sigma-Tau Pharmaceuticals, Inc. (Reporting) CIK: 0001385625 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091089720

Mailing Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000
Business Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000 1-800-447-0169
Sigma-Tau America S.A. (Reporting) CIK: 0001385930 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091089721